alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Interior

###### National Park Service

Notice is hereby given in accordance with the Federal Advisory Committee Act (Pub. L. 92-463) that the Boston Harbor Islands Advisory Council will meet on Wednesday, June 20, 2001. The meeting will convene at 3 p.m. at the New England Aquarium Conference Center, Central Wharf, Boston, MA.

The Advisory Council was appointed by the Director of National Park Service pursuant to Public Law 104-333. The 28 members represent business, educational/cultural, community and environmental entities; municipalities surrounding Boston Harbor; Boston Harbor advocates; and Native American interests. The purpose of the Council is to advise and make recommendations to the Boston Harbor Islands Partnership with respect to the development and implementation of a management plan and the operation of the Boston Harbor Islands National Recreation Area.

The Agenda for this meeting is as follows:

1. Call to Order, Introductions of Advisory Council members present

2. Review and Approval of Minutes of March meeting

3. Update on Activites since the March Meeting

4. Presenation of GMP status by NPS

5. Report from the Co-chairs

6. Island Events this season

7. Public Comment

8. Next Meeting

9. Adjourn

The meeting is open to the public. Further information concerning Council meetings may be obtained from the Superintendent, Boston Harbor Islands. Interested persons may make oral/written presentations to the Council or file written statements. Such requests should be made at least seven days prior to the meeting to: Superintendent, Boston Harbor Islands NRA, 408 Atlantic Avenue, Boston, MA, 02110, telephone (617) 223-8667.

May 17, 2001.

George E. Price, Jr.,

Superintendent, Boston Harbor Islands NRA.

[FR Doc. 01-14069 Filed 6-4-01; 8:45 am]

BILLING CODE 4310-70-P
```

[Federal Register: March 2, 2000 (Volume 65, Number 42)]
[Corrections]
[Page 11369]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02mr00-134]



[[Page 11369]]



COMMODITY FUTURES TRADING COMMISSION

RIN 3038-ZA08


Average Price Calculations by Futures Commission Merchants

Correction

    In notice document 00-1907 beginning on page 4807 in the issue of
Tuesday, February 1, 2000, make the following correction:
    On page 4808, in the second column, in paragraph 5., in the fourth
line remove ``maintains them in accounts''.

[FR Doc. C0-1907 Filed 3-1-00; 8:45 am]
BILLING CODE 1505-01-D
```

----

**======== RETURN TO INDEX    ========**

----
Exhibit 21.1


              Subsidiary Companies of Life Sciences Research, Inc.



Name                                                            Jurisdiction
----                                                            -----------

Huntingdon Life Sciences Group plc                             England & Wales

Huntingdon Life Sciences Ltd.                                  England & Wales

Huntingdon Life Sciences Inc.                                  Delaware, USA

HIH Capital Ltd.                                               Jersey

HIH Ltd.                                                       England & Wales

HRC Ltd.                                                       England & Wales

Huntingdon Research Centre Ltd.                                England & Wales

Huntingdon Consulting Engineers Ltd.                           England & Wales

Huntingdon LSR Ltd.                                            England & Wales

Paragon Global Services Ltd.                                   England & Wales

Pathfinder Clinical Development Ltd.                           England & Wales

Pathfinder Nominees Ltd.                                       England & Wales

Life Sciences Research Ltd.                                    England & Wales

Aquatox Ltd.                                                   England & Wales

Huntingdon Life Sciences Co., Ltd.                             Japan
exh102.htm




Exhibit 10.2




 


AMENDMENT TO LICENSE AGREEMENT







AMENDMENT TO LICENCE AGREEMENT dated November 23, 2009, between Neohydro Technologies Corp., hereinafter collectively referred to as “Licensee” and Gene Peckover, a Sole Proprietor and Genes Vettes of Lynden , a Washington corporation, hereinafter collectively referred to as "Licensor”.







WHEREAS, the parties desire to amended the agreement entered into between them on June 8, 2009 (the “Agreement”);







WHEREAS, the parties have not completed the performance of all of the terms and conditions of said Agreement; and,







WHEREAS, the parties desire to now amend said Agreement in order to modify


certain terms of the Agreement..







NOW THEREFORE, in consideration of the mutual promises contained herein, it is agreed that the Agreement dated the 8th day of June 2009 is amend in the following particulars:







Section 2.1, 4.1, and Exhibit B of the Agreement is deleted in its entirety and the following is substituted therefore:







2.1. Except as set forth in paragraph 3 of this Agreement, and subject to the provisions of paragraphs 2.2 and 4 below, Licensor hereby grants to Licensee an exclusive license during the Term of this Agreement in the territory of Canada, European Union, Scandinavia, mutually agreed areas of the USA, and other such territories that shall be mutually agreed upon to market, sell, and distribute Licensor Technology (“License”) unless otherwise stated herein:








	
(a)      

	
The License Price for the License, shall be allocated as set out in Exhibit B; and












4.1. Licensor hereby grants to Licensee an exclusive license during the Term of this Agreement in the territory of Canada, European Union, Scandinavia, and mutually agreed areas of the USA.  Other territories shall be mutually agreed upon to market, sell, and distribute Licensor Technology as mutually agreed upon.  There are no other Restrictions.












 


 




 














  





1











  


























EXHIBIT B







LICENSE PRICE












As per this Agreement and the License Price, the Licensee and Licensor accept and agree to the following terms:








	
1)  

	
To purchase and have operational One Demonstration Unit by September 30, 2010.








	
2)  

	
To sell at least 3 units by December 31, 2011.








	
3)  

	
To sell at least 25 units by December 31, 2012.








	
4)  

	
To sell at least 200 units by December 31, 2013.








	
5)  

	
To sell at least 500 units by December 31, 2014.

















All other provisions of the Agreement dated the 8th day of June 2009 shall remain in full force and effect.







IN WITNESS WHEREOF, this Amendment to Agreement has been duly executed by the parties this 14th day of July 2010.







Licensee







Neohydro Technologies Corp.












MICHAEL KULCHESKI


By: Michael Kulcheski







Licensor 







Genes Vettes of Lynden







GENE PECKOVER


By: Gene Peckover, Sole Proprietor, as President of Genes Vettes to be incorporated































  





2
# C_2010343EN.01001701.xml

| 17.12.2010 | EN | Official Journal of the European Union | C 343/17 |
| --- | --- | --- | --- |

17.12.2010

EN

Official Journal of the European Union

C 343/17

---

Information communicated by Member States regarding closure of fisheries

2010/C 343/11

In accordance with Article 35(3) of Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Community control system for ensuring compliance with the rules of the common fisheries policy (1), a decision has been taken to close the fishery as set down in the following table:

1

| Date and time of closure | 7.5.2010 |
| --- | --- |
| Duration | 7.5.2010-31.12.2010 |
| Member State | Portugal |
| Stock or Group of stocks | COD/1/2B. |
| Species | Cod (Gadus morhua) |
| Zone | International waters of I and IIb |
| Type(s) of fishing vessels | — |
| Reference number | — |

Date and time of closure

7.5.2010

Duration

7.5.2010-31.12.2010

Member State

Portugal

Stock or Group of stocks

COD/1/2B.

Species

Cod (Gadus morhua)

Gadus morhua

Zone

International waters of I and IIb

Type(s) of fishing vessels

—

Reference number

—

Web link to the decision of the Member State:

http://ec.europa.eu/fisheries/cfp/fishing_rules/tacs/index_en.htm

---

(1)  OJ L 343, 22.12.2009, p. 1.

1

---
<PAGE>
                                                                    Exhibit 99.1

               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the annual report on Form 10-K of Applix, Inc. (the
"Company") for the period ended December 31, 2001 as originally filed with the
Securities and Exchange Commission on April 1, 2002 and as amended on the date
hereof (the "Report"), the undersigned, David Mahoney, Chief Executive Officer
of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

     (1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


                              /s/ David Mahoney
                              --------------------------
Dated: March 31, 2003         David Mahoney
                              Chief Executive Officer

A signed original of this written statement required by Section 906 has been
provided to Applix, Inc. and will be retained by Applix, Inc. and furnished to
the Securities and Exchange Commission or its staff upon request.
#### The People of the State of New York, Respondent, v Michael Brunner, Appellant.

Submitted May 17, 2010;

decided June 3, 2010

Motion for assignment of counsel granted and Richard M. Greenberg, Esq., Office of the Appellate Defender, 11 Park Place, Suite 1601, New York, NY 10007 assigned as counsel to the appellant on the appeal herein.
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Homeland Resources Ltd. (the “Company”)
on Form 10-Q for the period ending April 30, 2008, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Armando Garcia,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:  June
13, 2008













/s/ Armando
Garcia  Armando
Garcia,


President,
Secretary & Treasurer


(principal
executive and financial officer)
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 260 | The Woodlands, Texas 77381

Chapter 1133

Natural Gas Fixed Swap - Chicago Fixed (CAD/MMBtu)

DESCRIPTION

A monthly cash settled swap based upon the settlement price published by NGI for the location 

specified in the Floating Price A.

FLOATING PRICE A

The Floating Price for each contract month is equal to the monthly price for Chicago City Gate, 

as published by NGI.

CONTRACT UNIT AND VALUE

The contract quantity shall be in MMBTU. Each contract shall be valued as the contract quantity 

in MMBTU, multiplied by the settlement price.

LISTING CYCLE

Up to 108 consecutive monthly Contract Periods.

PRICES AND FLUCTUATIONS

Prices shall be quoted in Canadian dollars and cents per MMBTU. The minimum price fluctuation 

shall be $0.001 per MMBTU. The minimum price increment will be $0.0001. There shall be no 

maximum price fluctuation.

TERMINATION OF TRADING

Trading shall cease one Business Day prior to the first calendar day of the Contract Period.

FINAL SETTLEMENT

Delivery under the contract shall be by cash settlement in Canadian Dollars. Final settlement, 

following termination of posting for a contract month, will be based on the Floating Price A.

CURRENCY CONVERSION

Daily WRM Noon Rate for CAD per unit of USD as reporting by Refinitiv.
Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of
Strategic Storage Trust, Inc., (the Company), in connection with the Companys Quarterly Report on Form 10-Q for the period ended June 30, 2010 (the Report) hereby certifies, to his knowledge, that:



| | (i) | the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------



| | (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | ---- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |     |  |                                                                                       
|---------------------- |  | --- |  | --------------------------------------------------------------------------------------
|Dated: August 11, 2010 |  | By: |  | /s/ Michael S. McClure                                                                
|                       |  |     |  | Michael S. McClure
Chief Financial Officer and Treasurer
(Principal Financial Officer)
Exhibit 99.2

NEWS RELEASE



May 3, 2006



CONTACT:

|Sam Reinkensmeyer
Chief Financial Officer
CNS, Inc.
(952) 229-1500
sreinkensmeyer@cns.com
Nasdaq: CNXS | Joseph Diaz, Jr.
Lytham Partners, LLC
(602) 889-9700
diaz@lythampartners.com
|------------------------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------







CNS, Inc. Increases Quarterly Dividend



MINNEAPOLIS, May 3, 2006  CNS, Inc. (Nasdaq: CNXS), the Breathe Right® company, today announced that its board of directors has increased the companys quarterly cash dividend from six to seven cents per share of common stock, a 17% increase. The dividend is payable on June 9, 2006, to shareholders of record as of May 26, 2006.



Due to our continued strong financial performance, we are pleased to increase the dividend for the third time in three years said Marti Morfitt, president and chief executive officer of CNS. This action reflects the boards confidence in our financial performance and the long term-prospects of CNS.



CNS declared its first quarterly dividend in August 2003 and then raised the dividend payment in June 2004 and June 2005. The company has approximately 14 million shares outstanding.



About CNS, Inc.

CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right® nasal strips
and FiberChoice® dietary fiber supplements. The company focuses on products that address important consumer needs
within the aging well/self-care market, including better breathing and digestive health. Its common stock is listed on the Nasdaq
National Market under the ticker symbol CNXS. More information about CNS and its products is available at
www.cns.com.



Some of the information contained in this news release is forward-looking and subject to certain business risks as described in
the companys filings with the Securities and Exchange Commission, including those referred to in its Annual Report on Form
10-K for the year ended March 31, 2005. This news release contains forward-looking statements, which involve risks and
uncertainties.



###

---
#### James D. Lee, Respondent, v Astoria Generating Company, L.P, et al., Appellants/Third-Party Plaintiffs-Appellants. Elliott Turbomachinery Co., Inc., et al., Third-Party Defendants-Appellants.

Submitted January 19, 2010;

decided March 25, 2010

Motion for reargument denied with $100 costs and necessary reproduction disbursements *[see*13 NY3d 382 (2009)].
No. —, original.

#### Ex parte Murphy.

October 12, 1931.

*Mr. James Edward Murphy, pro se.*

The motion for leave to file a petition for writ of mandamus is denied.
EXHIBIT 21.1

                         SUBSIDIARIES OF THE REGISTRANT

Puradyn Filter Technologies, Ltd., a U.K. limited company
1177 Avenue of Americas

New York, New York 10036

August 14, 2023

Submitted via CFTC Portal

Mr. Christopher J. Kirkpatrick

Office of the Secretariat

Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

Re: TW SEF LLC - Rule Changes - Fully Integrated API Services Fee Schedule (Rate Swaps)

Dear Mr. Kirkpatrick:

Pursuant to Section 5c(c) of the Commodity Exchange Act (the “Act”) and Section 40.6(a) of the regulations of 

the Commodity Futures Trading Commission (the “Commission”), Tradeweb SEF LLC (“TW SEF”) hereby 

submits amendments to its Fully Integrated API Services Fee Schedule (Rate Swaps) (“Fee Schedule”), which 

have been amended to reflect updates to certain terms and fees. The amendments will become effective on 

November 1, 2023, which is more than ten business days from the date hereof. Pursuant to Commission 

Regulations 40.8 and 145.9(d), attached as Appendix A is the update to the Fee Schedule, with the additions 

and deletions indicated in redline format. In connection with this submission, TW SEF hereby notifies the 

Commission that:

1. Pursuant to CFTC Regulations 40.8 and 145.9, TW SEF is seeking to keep certain information 

confidential because it would otherwise reveal trade secrets or confidential commercial or financial 

information and has posted a notice of pending certification with the Commission and a redacted 

copy of this submission on TW SEF’s website.

2. TW SEF certifies that the Rule complies with the Act and the Commission’s regulations thereunder, 

including Core Principle 2 (Compliance with rules), as the Fee Schedule is a rule of the SEF; and

3. No substantive opposing views with respect to the Rule were expressed to TW SEF by its 

governing board or committee members, members of TW SEF or market participants.

If you have any questions, please do not hesitate to contact the undersigned at (646) 767-4923 or by email at 

Devi.Shanmugham@tradeweb.com.

Very truly yours,

Devi Shanmugham

TW SEF CCO
CONFIDENTIAL TREATMENT REQUESTED BY TW SEF LLC PURSUANT TO 17 CFR PART 145

APPENDIX A

Fully Integrated API Services Fee Schedule (Rate Swaps) 

(Blackline and Clean Copies)

[REDACTED]
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Annual Report of Life Sciences Research, Inc.
("LSR") on Form 10-K for the period ended December 31, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Andrew
H Baker, Chairman of the Board and Chief Executive Officer of LSR certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

1.   The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of LSR.




Date:    March 14, 2007                          /s/    Andrew H Baker
                                                        --------------------
                                                        Andrew H Baker
                                                        Chief Executive Officer
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: Karen Kristine Silvio v. Jason B. Ostrom and Nicole Sain

Appellate case number: 01-11-00293-CV

Trial court case number: 937164

Trial court: County Civil Court at Law No. 2 of Harris County

On January 31, 2013, the Court denied appellant’s “Motion to Request that the Affidavit 

of Indigence Filed with her Docketing Statement be Approved.” A motion for rehearing, if any, 

was due by February 15, 2013. See TEX. R. APP. P. 49.1. A motion for extension of time to file 

a motion for rehearing was due by March 4, 2013. See TEX. R. APP. P. 49.8. 

Appellant e-filed a motion to reconsider the order on March 14, 2013. Appellant e-filed 

a motion for extension of time to file the motion to reconsider on March 15, 2013. These 

motions were not timely filed.

Accordingly, appellant’s motion for extension of time to file the motion for 

reconsideration is denied. See TEX. R. APP. P. 49.8. We strike appellant’s motion for 

reconsideration. See TEX. R. APP. P. 49.1.

It is so ORDERED.

Judge’s signature: /s/ Laura C. Higley

 Acting individually  Acting for the Court

Date: April 11, 2013
---

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICERPURSUANT
TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Theron Resource
Group (the Company) on Form 10-Q for the quarter ended February 29, 2008, as
filed with the Securities and Exchange Commission on the date hereof (the
Periodic Report), I, Jerry R. Satchwell, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1. | the Periodic Report fully complies with the requirements
      of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
    and                                 
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                          
|2. | the information contained in the Periodic Report fairly
      presents, in all material respects, the financial condition and results of
      operations of the Company.

Dated: June 11, 2008

/s/             
 Jerry R. Satchwell

Jerry R. Satchwell Chief Executive
Officer

---